XML 214 R31.htm IDEA: XBRL DOCUMENT v3.20.2
Share-based Compensation (Tables)
6 Months Ended
Jun. 30, 2020
Share-based Payment Arrangement [Abstract]  
Schedule of Share-based Compensation Expense
During the periods presented, the Company recorded the following share-based compensation expense for stock options and restricted stock awards:
Three Months Ended June 30,Six Months Ended June 30,
2020201920202019
(in thousands)
Sales, general and administrative $1,139  $1,413  $2,446  $2,681  
Research and development418  481  740  1,049  
Total $1,557  $1,894  $3,186  $3,730  
Schedule of Stock Options
Stock Options
 Number of Options OutstandingWeighted-Average Exercise PriceWeighted-Average Remaining Contractual Term (in years)Aggregate Intrinsic Value (in thousands)
Balances at December 31, 20191,837,576  $14.54  8.06$24,122  
Granted (weighted-average fair value of $10.64 per share)
367,265  19.11  
Exercised(62,457) 5.99  
Forfeited/canceled(97,750) 15.70  
Balances at June 30, 20202,044,634  $15.57  8.04$10,046  
Schedule of Employee Stock Options Valuation Assumptions
The fair value of stock options granted to employees was estimated using the following assumptions:
Six Months Ended June 30,
20202019
Volatility
55% - 60%
56%
Risk-free interest rate
0.4% - 1.5%
1.9% - 2.6%
Term (in years)6.256.25
Dividend yield
The fair value of stock options granted to consultants was estimated using the following assumptions during the following periods presented:
Six Months Ended June 30,
20202019
Volatility
56% - 60%
57%
Risk-free interest rate
0.6% - 1.6%
2.1%
Term (in years)1010
Dividend yield
Schedule of Restricted Stock
The following table represents RSA activity for fiscal 2020:
 Restricted Stock Awards Weighted-
Average
Grant Date
Fair Value
Outstanding unvested at December 31, 2019128,682  $11.81  
Granted—  —  
Vested(16,864) 12.53  
Forfeited/canceled(9,148) 9.55  
Outstanding unvested at June 30, 2020102,670  $11.90